Drugdu.com expert's response:

The advancement of medical detection technologies enables the discovery of more potential diseases through various means, which are specifically reflected in the following aspects:

High-Sensitivity Detection Technologies: High-sensitivity detection methods can detect minute changes in biomarkers at an earlier stage. For instance, high-sensitivity troponin detection technology can identify the release of troponin during the early phase of myocardial cell injury, thereby supporting the early diagnosis of acute coronary syndrome and myocardial infarction. This technology can uncover early lesions that might be missed by traditional methods.

Multimodal Data Fusion and Comprehensive Analysis: By integrating data from multiple detection modalities, such as electrocardiograms (ECGs), echocardiograms, and blood tests, medical detection technologies can provide more comprehensive health information. This multimodal data fusion enhances diagnostic accuracy and helps identify potential disease risks that might be overlooked by a single detection method.

Artificial Intelligence (AI) and Big Data Analytics: AI technologies can process and analyze vast amounts of medical data, uncovering subtle features and patterns that human doctors might miss. For example, AI can predict the risk of various diseases in advance by analyzing changes in blood proteins. AI-assisted image analysis technologies, such as microscope AI, improve the accuracy and efficiency of cell recognition, enabling the detection of early lesions.

Discovery and Application of Emerging Biomarkers: With ongoing research, an increasing number of emerging biomarkers are being discovered and applied in clinical settings. For instance, biomarkers like Galectin-3 and ST2 have shown significant potential in the diagnosis of heart diseases. The detection of these biomarkers aids in more accurately assessing disease risks and prognoses.

Rapid Testing and Point-of-Care Testing (POCT): The development of rapid testing kits and point-of-care testing devices enables on-site or bedside rapid testing. These devices are user-friendly, have short detection times, and meet the needs for rapid clinical diagnosis, facilitating the timely discovery of potential diseases.

Liquid Biopsy Technology: By detecting biomarkers such as circulating tumor cells and extracellular vesicles in the blood, liquid biopsy technology holds promise for the early diagnosis and personalized treatment of diseases. This non-invasive detection method offers a new avenue for the early detection of diseases.

Single-Cell Sequencing and Precision Medicine: Single-cell sequencing technology can provide more detailed cellular information and elucidate cellular heterogeneity. This helps reveal the cellular mechanisms underlying disease onset, progression, and treatment responses, supporting precision medicine. Through single-cell sequencing, early cellular-level lesions can be discovered, guiding personalized treatment strategies.